AMAR

Amar Remedies Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on February 09, 2012, has accorded their approval to the following items : (1) To raise an additional funds by way of issue of Securities including equity shares and/or equity linked securities and/ or Compulsory Convertible Debentures and/or GDR and/or ADR and/or Non-Convertible Debentures with Detachable Warrants through any permissible route including through a Qualified Institutions Placement upto US $ 90 million (US $ Ninety Million only) in supersession of the earlier shareholde

Amar Remedies Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on August 26, 2011 has transacted the following business : (1) To issue Non-Convertible Debentures (NCDs) with detachable Convertible Warrants upto Rs.200.00 Cr. (Rupees Two Hundred Crores Only).

Amar Remedies Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 06, 2011 have approved the following: (1) To raise an additional funds by way of issue of GDR/FCCB/QIP/NCD/CCD and issue of Shares/ Share Warrants/Debentures to the Qualified Institutional Buyers (QIB) upto $60 million ($ Sixty million only) (2) To sell excess and unutilized factory Land and Building as a part of Strategic Planning. The Board of Directors has decided to obtain shareholders' approval for the above mentioned points through Postal Ballot.

Amar Remedies Limited has informed the Exchange that the Board of Directors has accorded their approval to the following items at the Board Meeting held on April 24, 2010, (1) To raise an additional funds by way of issue of FCCB/GDR/QIP/NCD/CCD to the extent of $60 million ($ Sixty million only) (2) To increase the Authorised Share Capital of the Company from existing Rs. 28 Crores (Rupees Twenty Eight Crores) to Rs. 50 Crores (Rupees Fifty Crores Only) (3) To approve the Employees Stock Option Scheme (ESOS) under which options carrying right to acquire up to 10 lacs (Ten Lacs Only) Equity Sha

Amar Remedies Limited has informed the Exchange that the Board of Directors at its meeting held on March 31, 2010, reappointed Mr. Sagar P. Shah as Managing Director of the Company for the period of 5 years w.e.f. April 01, 2010.

Amar Remedies Limited has informed the Exchange that the Board of Directors at their meeting held on November 23, 2009, the board has not considered issuing Pref. issue of Equity Shares / Warrants to the promoters at present and deferred its decision on the same at a future date.

Amar Remedies Limited has informed the Exchange that at the Board of Directors meeting held on September 23, 2006, the following decisions were made: (1) Annual General Meeting will be held on October 27, 2006.(2) Work at Dehradun plant is in full progress and company expect to start commercial production from January, 2007.(3) Work at Surat plant is in completion stage and commercial production will start from October 2, 2006.

Amar Remedies Limited has informed the Exchange that the BODs meeting to be convened on October 07, 2005 to consider and approve setting up of an additional manufacturing facility at Deharadun, to manufacture toothpaste and few Ayurvedic products, at the same time to assess situation of Surat project for implementation, has been postponed. The Company shall inform the next date at a later stage.